Volume 4, Issue 3 (Summer 2018)                   Caspian.J.Neurol.Sci 2018, 4(3): 128-133 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghayeghran A, Hashemi S T, Razzagh A, Salehi S. The Prevalence of Diabetes Mellitus in Patients With Migraine: A Cross-Sectional Study in Iran. Caspian.J.Neurol.Sci 2018; 4 (3) :128-133
URL: http://cjns.gums.ac.ir/article-1-235-en.html
1- Department of Neurology, Poursina Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
2- Neuroscience Research Center, Department of Neurology, Guilan University of Medical Sciences, Rasht, Iran , k.poursinal@gmail.com
3- Safety Promotion and Injury Prevention Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Neuroscience Research Center, Department of Neurology, Guilan University of Medical Sciences, Rasht, Iran
Abstract:   (2194 Views)
Background: Headache is one of the most common medical complaints occur in all ages. Migraine is the second leading cause of headache and is associated with many other disorders, such as obesity and metabolic syndromes. 
Objectives: This study aimed to determine the prevalence of diabetes mellitus in patients with migraine referring to the neurological clinic.
Materials & Methods: This descriptive cross-sectional study was performed on patients with migraine headache or history of migraine based on the International Headache Society (IHS) criteria referring to a neurology clinic in the north of Iran in 2016. The obtained data were entered in SPSS V. 22. The qualitative information were shown by average and standard deviation, also frequency and percentage were used to present nominal information.
Results: A total of 360 qualified patients were studied. Their Mean±SD age was 33.25±10.64 years. About 31.1% of participants were female. A total of 31 patients (9.4% of all under study population) had diabetes mellitus.
Conclusion: The prevalence of diabetes mellitus in patients with migraine was 9.4% which is close to what reported in normal population.
Full-Text [PDF 947 kb]   (586 Downloads) |   |   Full-Text (HTML)  (657 Views)  
Type of Study: Research | Subject: Special
Received: 2018/02/2 | Accepted: 2018/06/10 | Published: 2018/07/1

1. Farhadi Z, Alidoost S, Behzadifar M, Mohammadibakhsh R, Khodadadi N, Sepehrian R, al. The prevalence of migraine in Iran: A systematic review and meta-analysis. Iran Red Crescent Med J. 2016; 18(10):e40061. [DOI:10.5812/ircmj.40061] [DOI:10.5812/ircmj.40061]
2. Miri A, Nasiri M, Zonoori S, Yarahmad F, Dabbagh-Moghadam A, Askari G, et al. The association between obesity and migraine in a population of Iranian adults: A case-control study. Diabetes Metab Syndr: Clin Res Rev. 2018; 12(5):733-6. [DOI:10.1016/j.dsx.2018.04.020] [DOI:10.1016/j.dsx.2018.04.020]
3. Rainero I, Govone F, Gai A, Vacca A, Rubino E. Is migraine primarily a metaboloendocrine disorder. Curr Pain Headache Rep. 2018; 22(5):36. [DOI:10.1007/s11916-018-0691-7] [DOI:10.1007/s11916-018-0691-7]
4. Hossain MA, Hakim M, Hasan M, Rahman MA, Rashid M, Sagir G, et al. Socio-demographic and comorbidity profiles of migraine patients in a headache clinic of a tertiary care hospital in Dhaka City. J Natl Inst Neurosci Bangladesh. 2017; 3(1):48-51. [DOI:10.3329/jninb.v3i1.36272] [DOI:10.3329/jninb.v3i1.36272]
5. Woldeamanuel Y, Cowan R. Worldwide migraine epidemiology: Systematic review and meta-analysis of 302 community-based studies involving 6,216,995 participants. Neurol. 2016; 86(Suppl 16):P6-100. [DOI:10.1016/j.jns.2016.11.071] [DOI:10.1016/j.jns.2016.11.071]
6. Bhoi SK, Kalita J, Misra UK. Metabolic syndrome and insulin resistance in migraine. J Headache Pain. 2012; 13(4):321-6. [DOI:10.1007/s10194-012-0416-y] [DOI:10.1007/s10194-012-0416-y]
7. Guldiken B, Guldiken S, Taskiran B, Koc G, Turgut N, Kabayel L, et al. Migraine in metabolic syndrome. Neurologist. 2009; 15(2):55-8. [DOI:10.1097/NRL.0b013e31817781b6] [DOI:10.1097/NRL.0b013e31817781b6]
8. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol, Neurosurg Psychiatry. 2010; 81(4):428-32. [DOI:10.1136/jnnp.2009.192492] [DOI:10.1136/jnnp.2009.192492]
9. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine The GEM population-based study. Neurol. 2005; 64(4):614-20. [DOI:10.1212/01.WNL.0000151857.43225.49] [DOI:10.1212/01.WNL.0000151857.43225.49]
10. Rainero I, Limone P, Ferrero M, Valfrè W, Pelissetto C, Rubino E, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia. 2005; 25(8):593-7. [DOI:10.1111/j.1468-2982.2005.00928.x] [DOI:10.1111/j.1468-2982.2005.00928.x]
11. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine a population study. Neurol. 2006; 66(4):545-50. [DOI:10.1212/01.wnl.0000197218.05284.82] [DOI:10.1212/01.wnl.0000197218.05284.82]
12. Aamodt AH, Stovner LJ, Midthjell K, Hagen K, Zwart JA. Headache prevalence related to diabetes mellitus: The Head-HUNT study. Eur J Neurol. 2007; 14(7):738-44. [DOI:10.1111/j.1468-1331.2007.01765.x] [DOI:10.1111/j.1468-1331.2007.01765.x]
13. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008; 49(7):571-6. [PMID] [PMID]
14. Azizi F, Rahmani M, Emami H, Mirmiran PA, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 2002; 47(6):408-26. [PMID] [DOI:10.1007/s000380200008] [PMID]
15. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetol. 2003; 46(9):1190-8. [DOI:10.1007/s00125-003-1167-8] [PMID] [DOI:10.1007/s00125-003-1167-8]
16. Haghdoost AA, Rezazadeh Kermani M, Sadghirad B, Baradaran HR. Prevalence of type 2 diabetes in the Islamic Republic of Iran: Systematic review and meta-analysis. East Mediterr Health J. 2009; 15(3):591-9. [PMID] [DOI:10.26719/2009.15.3.591] [PMID]
17. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006; 296(3):283-91. [DOI:10.1001./jama.296.3.283] [DOI:10.1001/jama.296.3.283] [PMID]
18. Sillanpää M, Aro H. Headache in teenagers: Comorbidity and prognosis. Funct Neurol. 2000; 15(Suppl 3):116-21. [PMID] [PMID]
19. Burch RC, Rist PM, Winter AC, Buring JE, Pradhan AD, Loder EW, et al. Migraine and risk of incident diabetes in women: A prospective study. Cephalalgia. 2012; 32(13):991-7. [DOI:10.1177/0333102412453954] [PMID] [DOI:10.1177/0333102412453954]
20. Berge LI, Riise T, Fasmer OB, Hundal Ø, Oedegaard KJ, Midthjell K, et al. Does diabetes have a protective effect on migraine. Epidemiol. 2013; 24(1):129-34. [DOI:10.1097/EDE.0b013e31827623d0] [DOI:10.1097/EDE.0b013e31827623d0]
21. Melmed S. Williams textbook of endocrinology. Amsterdam: Elsevier Health Sciences; 2016.
22. Ghayeghran AR, Dehnadi Moghadam A, Sedighi Moghadam P. [Survey of Teachers' Knowledge about Migraine in Rasht in 2005 (Persian)]. J Guilan Univ Med Sci. 2007; 16(61):51-9.
23. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, et al. Headache, cerebrovascular symptoms, and stroke The Atherosclerosis Risk in Communities Study. Neurol. 2005; 64(9):1573-7. [DOI:10.1212/01.WNL.0000158326.31368.0] [PMID] [DOI:10.1212/01.WNL.0000158326.31368.04] [PMID]
24. Liew G, Wang JJ, Mitchell P. Migraine and coronary heart disease mortality: A prospective cohort study. Cephalalgia. 2007; 27(4):368-71. [DOI:10.1111/j.1468-2982.2007.01298.x] [PMID] [DOI:10.1111/j.1468-2982.2007.01298.x]
25. Rosamond W. Are migraine and coronary heart disease associated? An epidemiologic review. Headache: J Head Face Pain. 2004; 44:S5-12. [DOI:10.1111/j.1526-4610.2004.04103.x] [DOI:10.1111/j.1526-4610.2004.04103.x]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Caspian Journal of Neurological Sciences

Designed & Developed by : Yektaweb